DZ Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

DZ Bank’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-26,800	Closed	-$875K	–	1166
2018 Q1	$875K	Buy	+26,800	New	+$1.18M	﹤0.01%	688

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

DZ Bank's PTLA Position: Q2 2018 in Review

DZ Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2018, closing a stake of 26,800 shares — an estimated $875K sold.

DZ Bank first reported a position in PTLA in Q1 2018 and held it in 1 quarter. The position peaked at $875K in Q1 2018. 204 funds tracked by Wall St. Rank hold PTLA as of Q2 2018.

DZ Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 26,800 Portola Pharmaceuticals, Inc. shares in Q2 2018, an estimated $875K.
DZ Bank first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
DZ Bank's Portola Pharmaceuticals, Inc. position peaked at $875K in Q1 2018.
204 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.